<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05096078</url>
  </required_header>
  <id_info>
    <org_study_id>GestationalDM.Exer.Cog.</org_study_id>
    <nct_id>NCT05096078</nct_id>
  </id_info>
  <brief_title>The Effect of Circuit Exercise Program in Gestational Diabetes</brief_title>
  <official_title>The Effect of Circuit Exercise Program on Cognitive Function, Functional Exercise Capacity, Mobility, Depression and Quality of Life in Women With Gestational Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul Medipol University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul Medipol University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gestational diabetes (GDM) is defined as 'pregnancy-onset or first noticed glucose&#xD;
      intolerance'. The aim of this study is to investigate the effect of circuit exercise program&#xD;
      applied in addition to diet therapy on cognitive function, functional exercise capacity,&#xD;
      mobility, depression and quality of life in women with gestational diabetes. 60 female&#xD;
      participants between the ages of 18-35 who meet the inclusion criteria will be included in&#xD;
      the study. Participants will be randomly divided into 2 groups as diet group (n=30) and&#xD;
      exercise group (n=30). All participants will receive GDM-specific dietary therapy for 6&#xD;
      weeks. In addition to diet therapy, individuals in the exercise group will be given a circuit&#xD;
      exercise program for 6 weeks. Participants will be evaluated for blood values, cognitive&#xD;
      status and functionality at the baseline and 6 weeks later.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 16, 2020</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood count</measure>
    <time_frame>6 weeks after baseline</time_frame>
    <description>Participants' fasting blood glucose (FBG), postprandial blood glucose (PBG), HbA1c, insulin, total cholesterol (T-col), high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL), triglyceride (TG) values will be recorded. .</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Montreal Cognitive Assessment Scale</measure>
    <time_frame>6 weeks after baseline</time_frame>
    <description>It is a screening scale developed to evaluate the early stages of cognitive impairment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>WMS Number Range Test</measure>
    <time_frame>6 weeks after baseline</time_frame>
    <description>In the forward number range, the patient is asked to repeat the numbers told to her in the same order, and in the backward number range, the patient is asked to repeat the said numbers from the end to the beginning.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Gestational Diabetes</condition>
  <arm_group>
    <arm_group_label>Diet Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Individuals will receive only dietary treatment that the dietitian deems appropriate for 6 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In addition to the 6-week diet program that the dietitian deems appropriate, a circuit exercise program will be applied for 6 weeks. The circuit exercise program will consist of a medium-intensity circuit training for 50 minutes, 3 days a week, detailing the main muscle groups of the patients (chest, back, biceps, triceps, deltoid, quadriceps, thigh and calf muscles). Exercise intensity will be monitored using Borg's scale of perceived exertion, with a target intensity of 12 to 14. 8 exercises will be given in a continuous, circuit-type manner with short 1-minute rests.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diet</intervention_name>
    <description>Special diet program for gestational diabetes</description>
    <arm_group_label>Diet Group</arm_group_label>
    <arm_group_label>Exercise Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>The circuit exercise program will consist of a medium-intensity circuit training for 50 minutes, 3 days a week, detailing the main muscle groups of the patients (chest, back, biceps, triceps, deltoid, quadriceps, thigh and calf muscles). Exercise intensity will be monitored using Borg's scale of perceived exertion, with a target intensity of 12 to 14. 8 exercises will be given in a continuous, circuit-type manner with short 1-minute rests.</description>
    <arm_group_label>Exercise Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  being diagnosed with gestational DM&#xD;
&#xD;
          -  being between the ages of 18-35&#xD;
&#xD;
          -  being in 24-32 weeks of pregnancy&#xD;
&#xD;
          -  being inactive physical activity level - (&lt;300 MET weeks/day)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnosed with diabetes before pregnancy&#xD;
&#xD;
          -  have given birth before&#xD;
&#xD;
          -  Multiple Pregnancy (&gt;2)&#xD;
&#xD;
          -  Intrauterine growth restriction&#xD;
&#xD;
          -  Preeclampsia&#xD;
&#xD;
          -  having high risk of preterm labor and on strict bed rest&#xD;
&#xD;
          -  treatment with insulin or oral hypoglycemic agents during pregnancy&#xD;
&#xD;
          -  Other significant severe or poorly controlled medical conditions (thyroid disease,&#xD;
             cardio-respiratory disorders, ...)&#xD;
&#xD;
          -  taking medications that affect cognitive function, including corticosteroids,&#xD;
             anti-depressants, or anti-epileptics&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miray BUDAK, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Medipol University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Saadet Turhan</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medipol University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Istanbul Medipol University</name>
      <address>
        <city>Istanbul</city>
        <state>Beykoz</state>
        <zip>34815</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 15, 2021</study_first_submitted>
  <study_first_submitted_qc>October 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2021</study_first_posted>
  <last_update_submitted>October 15, 2021</last_update_submitted>
  <last_update_submitted_qc>October 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul Medipol University Hospital</investigator_affiliation>
    <investigator_full_name>Miray Budak</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Gestational diabetes</keyword>
  <keyword>Circuit Exercise</keyword>
  <keyword>Cognition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

